Geneoscopy: Don Hardison
Don Hardison has been appointed as chairman of the board of Geneoscopy, a St. Louis-based developer of molecular diagnostic tests for gastrointestinal health. Hardison previously served as a strategic advisor to the company. He also previously served as president and CEO of Biotheranostics until its acquisition by Hologic in February 2021. Before that, he was president, CEO, and director at Good Start Genetics. Hardison was also president and CEO of Exact Sciences from 2000 to 2007, and has held multiple senior leadership positions at Labcorp, Quest Diagnostics, and SmithKline Beecham.